Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

La Jolla, California Clinical Trials

A listing of La Jolla, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (23) clinical trials

BEACH Trial: Bovine Early Access Compatibility and Hemostasis Trial

Chronic kidney disease (CKD) is a major health problem that affects approximately 26 million Americans. Many of those suffering CKD will progress to develop end stage renal disease (ESRD) and require lifelong hemodialysis (HD) to filter wastes from their blood. There are nearly 2.5 million patients who receive HD worldwide, ...

Phase

1.02 miles

Learn More »

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

In total there will be approximately 200 patients enrolled on the study around both sites. At the UCSD site there will be a total of 106 total subjects (53 active treatment and 53 control subjects) who are randomized into the treatment protocols having passed the screening criteria. At the UU ...

Phase N/A

1.02 miles

Learn More »

A Study of CC-99712 a BCMA Antibody-Drug Conjugate in Subjects With Relapsed and Refractory Multiple Myeloma

Study CC-99712-MM-001 is an open-label, Phase 1, dose escalation (Part A) and expansion (Part B), First-in-Human (FIH) clinical study of CC-99712 in subjects with relapsed and refractory multiple myeloma (MM). The dose escalation part (Part A) of the study will evaluate the safety and tolerability of escalating doses of CC-99712, ...

Phase

1.02 miles

Learn More »

PDGeneration: Mapping the Future of Parkinson's Disease

The purpose of this study is to evaluate how offering Clinical Laboratory Improvement Amendments (CLIA) certified genetic testing for Parkinson's Disease (PD) genes to people with Parkinson's Disease impacts clinical care and potential enrollment in clinical trials. This study will be a longitudinal, multi-center study to evaluate how providing CLIA-certified ...

Phase N/A

1.02 miles

Learn More »

A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors

This is an Phase 1, first-in-human, open-label, dose-escalation, and dose-expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics and preliminary efficacy of MEDI5395 in combination with durvalumab in subjects with selected advanced solid tumors.

Phase

1.02 miles

Learn More »

The SNAP Trial: SPRINT Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain

The purpose of this study is to determine if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves in an individual's amputated leg.This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is made by SPR Therapeutics (the sponsor ...

Phase N/A

1.02 miles

Learn More »

Chronic Low Back Pain and Meditation

The purpose of this psychophysical and pharmacologic study is to determine if meditation induced pain relief is mediated by endogenous opioids in response to intravenous (IV) administration of the opioid antagonist naloxone during a pain evoking straight leg raise test in response to double-blind intravenous administration (IV) of naloxone/placebo-saline. The ...

Phase N/A

1.02 miles

Learn More »

Safety Tolerability and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH)

The primary objective of this study is to evaluate the safety and tolerability of study drug(s) in adults with nonalcoholic steatohepatitis (NASH).

Phase

1.42 miles

Learn More »

A Study of Nivolumab and Ipilimumab in Untreated Patients With Stage 3 NSCLC That is Unable or Not Planned to be Removed by Surgery

The primary purpose of the study is to compare the effectiveness of nivolumab + CCRT followed by nivolumab + ipilimumab (Arm A) vs CCRT followed by durvalumab (Arm C) in participants with untreated Locally Advanced Non-small Cell Lung Cancer

Phase

1.42 miles

Learn More »

A Study to Evaluate the Safety Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

TAK-079 is being tested in a study population with moderate to severe SLE. This study will evaluate the safety and biologic activity of TAK-079 or matching placebo in combination with stable SLE background therapy. The study will enroll approximately 24 participants across 3 sequentially enrolling cohorts. Each cohort will enroll ...

Phase

1.42 miles

Learn More »